Cargando…

SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes

Case reports of patients infected with COVID-19 and influenza virus (“flurona”) have raised questions around the prevalence and severity of coinfection. Using data from HHS Protect Public Data Hub, NCBI Virus, and CDC FluView, we analyzed trends in SARS-CoV-2 and influenza hospitalized coinfection c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawlowski, Colin, Silvert, Eli, O'Horo, John C, Lenehan, Patrick J, Challener, Doug, Gnass, Esteban, Murugadoss, Karthik, Ross, Jason, Speicher, Leigh, Geyer, Holly, Venkatakrishnan, A J, Badley, Andrew D, Soundararajan, Venky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Biological, Health, and Medical Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291226/ https://www.ncbi.nlm.nih.gov/pubmed/35860600 http://dx.doi.org/10.1093/pnasnexus/pgac071

Ejemplares similares

Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records
por: Niesen, Michiel J. M., et al.
Publicado: (2022)

Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
por: Niesen, Michiel J M, et al.
Publicado: (2022)

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection
por: Puranik, Arjun, et al.
Publicado: (2022)

Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
por: Puranik, Arjun, et al.
Publicado: (2021)

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021)

Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
por: Venkatakrishnan, A. J., et al.
Publicado: (2023)

FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
por: Pawlowski, Colin, et al.
Publicado: (2021)

Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
por: Lenehan, Patrick J., et al.
Publicado: (2021)

Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus
por: Pawlowski, Colin, et al.
Publicado: (2021)

Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
por: Pawlowski, Colin, et al.
Publicado: (2021)

Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)
por: Pawlowski, Colin, et al.
Publicado: (2020)

Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure
por: Niesen, Michiel J M, et al.
Publicado: (2022)

Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
por: Pawlowski, Colin, et al.
Publicado: (2021)

Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
por: Wagner, Tyler, et al.
Publicado: (2020)

Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
por: McMurry, Reid, et al.
Publicado: (2021)

Vaccination Safety: Don’t Toss the Champagne With the Cork
por: Shah, Aditya, et al.
Publicado: (2021)

Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
por: Ghosh, Pritha, et al.
Publicado: (2022)

Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications
por: Venkatakrishnan, A. J., et al.
Publicado: (2021)

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
por: Corchado-Garcia, Juan, et al.
Publicado: (2021)

Long-term SARS-CoV-2 RNA Shedding and its Temporal Association to IgG Seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

The Complication of Coinfection
por: Pasman, Lesley
Publicado: (2012)

Viral Coinfections
por: Du, Yanting, et al.
Publicado: (2022)

Benchmarking evolutionary tinkering underlying human–viral molecular mimicry shows multiple host pulmonary–arterial peptides mimicked by SARS-CoV-2
por: Venkatakrishnan, A. J., et al.
Publicado: (2020)

Continuous genomic diversification of long polynucleotide fragments drives the emergence of new SARS-CoV-2 variants of concern
por: Murugadoss, Karthik, et al.
Publicado: (2022)

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
por: Razonable, Raymund R., et al.
Publicado: (2021)

Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest
por: Anand, Praveen, et al.
Publicado: (2022)

On the Origins of Omicron’s Unique Spike Gene Insertion
por: Venkatakrishnan, A. J., et al.
Publicado: (2022)

Infectious disease physician characteristics and prescription of meropenem in the hospital
por: Challener, Douglas, et al.
Publicado: (2023)

Leishmaniasis and AIDS coinfection
por: Hozannah, Adriana, et al.
Publicado: (2013)

Determinants of Coinfection in the Mycoviruses
por: Thapa, Vaskar, et al.
Publicado: (2019)

Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registry
por: Kirkup, Christian, et al.
Publicado: (2021)

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021)

1340. The Effect of Continuous Renal Replacement Therapy on Body Temperature in Patients with and without Infection
por: Challener, Douglas W, et al.
Publicado: (2019)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

The nature and consequences of coinfection in humans
por: Griffiths, Emily C., et al.
Publicado: (2011)

The microbial coinfection in COVID-19
por: Chen, Xi, et al.
Publicado: (2020)

Cryptococcosis with Tuberculosis: Overlooked Coinfections
por: Suresh, Christina S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vo297hgsnq02j3ppfb9k5him6l